Compound Summary
药名: | Citromitin |
别名: | citromitin |
分子式: | C21H24O8 |
Smiles: | COC1=C(C=C(C=C1)C2CC(=O)C3=C(O2)C(=C(C(=C3OC)OC)OC)OC)OC |
成分: | HBIN020991 |
OB_score: | 86.904047 |
SymMap_id: | SMIT07519;SMIT18396 |
TCMID_id: | 23606 |
TCMSP_id: | MOL005815 |
PubChem_id: | 12303287 |
植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
---|
TCMBANKHE008690 | Pericarpium Citri Reticulatae | 陈皮 | To regulate the flow of qi, to invigorate the spleen function, to eliminate damp, and to resolve phlegm./Treatment of distension and fullness sensation in the chest and epigastrium with anorexia, vomiting and diarrhea, cough with copious phlegm. | |||
TCMBANKHE005199/YEM-416/XU-321 | Fructus Xanthii sibirici|Xanthium sibiricum Patrin ex Widder|Xanthium sibiricum | 苍耳子|苍耳 | 苍耳子 | 云南民族药物志:第二卷|贵州省毕节市赫章县 | To dispel wind and damp, and to relieve nasal obstruction./1. Lowering blood sugar, with similar mechanism as phenethyl biguanide ( DBI ). 2. Its chief poisonous component is rhamnose. The toxic effects in rats, guinea-pigs and rabbits by different routes of administration are similar. LD50 is 0.93g/kg in mice. | 阿昌族/白族/傣族/德昂族/哈尼族/景颇族/傈僳族/苗族/彝族/藏族 |
TCMBANKHE008726/YEM-890 | Citrus reticulata|Citrus reticulata Blanco | 橘皮(陈皮)|橘 | 橘 | 云南民族药物志:第五卷 | To rectify qi and downbear counterflow, regulate center and increase appetite, dry damp and transform phlegm./Spleen-stomach qi stagnation and damp obstruction, lung qi block, cough with profuse phlegm, mammary welling abscess, indigestion, vomiting. | 阿昌族/傣族/德昂族/基诺族/景颇族/傈僳族/水族/瑶族/彝族 |
TCMBANKHE005584/YEM-890 | Citrus reticulata|Citrus reticulata Blanco | 橘皮|橘 | 橘 | 云南民族药物志:第五卷 | To rectify qi and downbear counterflow, regulate center and increase appetite, dry damp and transform phlegm./Spleen-stomach qi stagnation and damp obstruction, lung qi block, cough with profuse phlegm, mammary welling abscess, indigestion, vomiting. | 阿昌族/傣族/德昂族/基诺族/景颇族/傈僳族/水族/瑶族/彝族 |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE000121 | KCNH2 | ERG-1; ERG1; H-ERG; HERG; HERG1; Kv11.1; LQT2; SQT1 | potassium voltage-gated channel subfamily H member 2 |
TCMBANKGE000181 | PIM1 | PIM | Pim-1 proto-oncogene, serine/threonine kinase |
TCMBANKGE000201 | ESR1 | ER; ESR; ESRA; ESTRR; Era; NR3A1 | estrogen receptor 1 |
TCMBANKGE000205 | NOS2 | HEP-NOS; INOS; NOS; NOS2A | nitric oxide synthase 2 |
TCMBANKGE000286 | GSK3B | - | glycogen synthase kinase 3 beta |
TCMBANKGE000309 | SCN5A | CDCD2; CMD1E; CMPD2; HB1; HB2; HBBD; HH1; ICCD; IVF; LQT3; Nav1.5; PFHB1; SSS1; VF1 | sodium voltage-gated channel alpha subunit 5 |
TCMBANKGE000476 | NCOA2 | GRIP1; KAT13C; NCoA-2; SRC2; TIF2; bHLHe75 | nuclear receptor coactivator 2 |
TCMBANKGE000701 | ESR2 | ER-BETA; ESR-BETA; ESRB; ESTRB; Erb; NR3A2; ODG8 | estrogen receptor 2 |
TCMBANKGE000766 | ACHE | ACEE; ARACHE; N-ACHE; YT | acetylcholinesterase (Cartwright blood group) |
TCMBANKGE000813 | DPP4 | ADABP; ADCP2; CD26; DPPIV; TP103 | dipeptidyl peptidase 4 |
TCMBANKGE001073 | PTGS2 | COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2 | prostaglandin-endoperoxide synthase 2 |
TCMBANKGE001185 | PPARG | CIMT1; GLM1; NR1C3; PPARG1; PPARG2; PPARG5; PPARgamma | peroxisome proliferator activated receptor gamma |
TCMBANKGE003643 | F7 | SPCA | coagulation factor VII |
TCMBANKGE004266 | AR | AIS; AR8; DHTR; HUMARA; HYSP1; KD; NR3C4; SBMA; SMAX1; TFM | androgen receptor |
TCMBANKGE006339 | CA2 | CA-II; CAC; CAII; Car2; HEL-76; HEL-S-282 | carbonic anhydrase 2 |
TCMBANKGE011079 | PRSS1 | TRP1; TRY1; TRY4; TRYP1 | serine protease 1 |